Search - tctmd.com

Displaying 221 - 240 of 437

Sort: Relevancy | Date

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement

Yael L. Maxwell

August 06, 2020

News Daily News

NSAIDs Boost CV, Bleeding Risks in Post-MI Patients

Todd Neale

July 28, 2020

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Shelley Wood

July 20, 2020

News Daily News

Thrombus Burden Greater in STEMI Patients With COVID-19

Michael O'Riordan

July 20, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Daily News

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Michael O'Riordan

May 04, 2020

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

News Daily News

Cardiac Considerations Amid COVID-19: Shared Stories May Save Lives

L.A. McKeown

March 25, 2020

News Daily News

Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises

Shelley Wood

February 14, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

News Conference News AHA 2019

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

Todd Neale

November 20, 2019

News Daily News

Grief and CVD: Simple Regimen May Lower Risk

L.A. McKeown

November 19, 2019

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

Advertisement

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement

NSAIDs Boost CV, Bleeding Risks in Post-MI Patients

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Thrombus Burden Greater in STEMI Patients With COVID-19

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Cardiac Considerations Amid COVID-19: Shared Stories May Save Lives

Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

Grief and CVD: Simple Regimen May Lower Risk

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Recurrent Events Common Among Young Patients With CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content